Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Objective: The objective of our study was to investigate the comparative effectiveness of antipsychotics for the risk of attempted or completed suicide among all patients with schizophrenia in Finland and Sweden. Methods: Two nationwide register-based cohort studies were conducted, including all individuals with schizophrenia in Finland (n = 61 889) and Sweden (n=29 823). The main exposure was 10 most commonly used antipsychotic monotherapies; also, adjunctive pharmacotherapies were investigated. The main outcome measure was attempted or completed suicide, which was analyzed with within-individual models by comparing use and nonuse periods in the same individual to minimize selection bias. Sensitivity analyses included attempted suicide (hospitalization only) as an outcome. Results: Compared with no use of antipsychotics, clozapine use was the only antipsychotic consistently associated with a decreased risk of suicidal outcomes. Hazard ratios (HRs) and 95% CIs for attempted or completed suicide were 0.64 (0.49–0.84) in the Finnish cohort and 0.66 (0.43–0.99) in the Swedish cohort. No other antipsychotic was associated with a reduced risk of attempted and/or completed suicide. Benzodiazepines and Z-drugs were associated with an increased risk of attempted or completed suicide (HRs: 1.29–1.30 for benzodiazepines and 1.33–1.62 for Z-drugs). Conclusion: Clozapine was the only antipsychotic associated with decreased risk of attempted or completed suicide among patients with schizophrenia, and it should be considered as first-line treatment for high-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment with clozapine has also been associated with decreased risk of suicide in adults with psychotic disorders, 142 but comparable studies in young people are lacking.”
From Suicide in young people: screening, risk assessment, and intervention (2023) · cites this paper as [142]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huhn, M., Nikolakopoulou, A., Schneider-Thoma, J., Krause, M., Samara, M., Peter, N., Arndt, T., Bäckers, L., Rothe, P., Cipriani, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31135-3 · Cited by 1,753
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Self-citationLithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920
Review: Suicide and schizophrenia: a systematic review of rates and risk factors
Hor, K., & Taylor, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385490 · Cited by 853
Tiihonen, J., Mittendorfer-Rutz, E., Majak, M., Mehtälä, J., Hoti, F., Jedenius, E., Enkusson, D., Leval, A., Sermon, J., Tanskanen, A., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1322 · Cited by 670
Self-citationMedication for Attention Deficit–Hyperactivity Disorder and Criminality
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203241 · Cited by 611
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Tanskanen, A., & Haukka, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1358 · Cited by 277
Self-citationPolypharmacy With Antipsychotics, Antidepressants, or Benzodiazepines and Mortality in Schizophrenia
Tiihonen, J. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1532 · Cited by 253
Self-citationClinical pharmacology of atypical antipsychotics: an update
Mauri, M. C., Paletta, S., Maffini, M., Colasanti, A., Dragogna, F., Di Pace, C., & Altamura, A. C. (2014) · Technische Universität Dortmund · doi:10.17877/de290r-7037 · Cited by 250
Cassidy, R. M., Yang, F., Kapczinski, F., & Passos, I. C. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx131 · Cited by 230
Tiihonen, J., Mittendorfer-Rutz, E., Torniainen, M., Alexanderson, K., & Tanskanen, A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15050618 · Cited by 203
Self-citationFrom prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
Tanskanen, A., Taipale, H., Koponen, M., Tolppanen, A.-M., Hartikainen, S., Ahonen, R., & Tiihonen, J. (2015) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-015-0140-z · Cited by 199
Self-citationSuicidal behaviour and mortality in first-episode psychosis: the OPUS trial
Bertelsen, M., Jeppesen, P., Petersen, L., Thorup, A., ⊘hlenschlæger, J., Quach, P. L., Christensen, T. Ø., Krarup, G., J⊘rgensen, P., & Nordentoft, M. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.191.51.s140 · Cited by 185
Unique Effects of Clozapine: A Pharmacological Perspective
Khokhar, J. Y., Henricks, A. M., Sullivan, E. D. K., & Green, A. I. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.09.009 · Cited by 182
Deployment-related stress and trauma in Dutch soldiers returning from Iraq: Prospective study
Engelhard, I. M., Van Den Hout, M. A., Weerts, J., Arntz, A., Hox, J. J. C. M., & McNally, R. J. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.034884 · Cited by 178
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
Westman, J., Eriksson, S. V., Gissler, M., Hällgren, J., Prieto, M. L., Bobo, W. V., Frye, M. A., Erlinge, D., Alfredsson, L., & Ösby, U. (2018) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000166 · Cited by 161
Taipale, H., Mehtälä, J., Tanskanen, A., & Tiihonen, J. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx176 · Cited by 153
Self-citationPrescribed Benzodiazepines and Suicide Risk: A Review of the Literature
Dodds, T. J. (2017) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.16r02037 · Cited by 144
Mortality in schizophrenia: 30-year nationwide follow-up study
Tanskanen, A., Tiihonen, J., & Taipale, H. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12913 · Cited by 134
Self-citationManaging Suicide Risk in Patients with Schizophrenia
Kasckow, J., Felmet, K., & Zisook, S. (2011) · CNS Drugs · doi:10.2165/11586450-000000000-00000 · Cited by 133
Suicidal Behavior and Mortality in First-Episode Psychosis
Nordentoft, M., Madsen, T., & Fedyszyn, I. (2015) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000296 · Cited by 132
Treatment of Suicidality in Schizophrenia
Meltzer, H. Y. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05797.x · Cited by 124 · cited 1×
“9–11 A nationwide forensic toxicological study on suicide deaths found that partial and full nonadherence to antipsychotics were associated with applyparastyle "fig//caption/p[1]" parastyle "FigCapt"”
BackgroundKrause, M., Huhn, M., Schneider-Thoma, J., Bighelli, I., Gutsmiedl, K., & Leucht, S. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.1105 · Cited by 86
Schneider-Thoma, J., Efthimiou, O., Huhn, M., Krause, M., Reichelt, L., Röder, H., Davis, J. M., Salanti, G., & Leucht, S. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30177-9 · Cited by 81
Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
Pompili, M., Baldessarini, R., Forte, A., Erbuto, D., Serafini, G., Fiorillo, A., Amore, M., & Girardi, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101700 · Cited by 78
Ringbäck Weitoft, G., Berglund, M., Lindström, E. A., Nilsson, M., Salmi, P., & Rosén, M. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3567 · Cited by 77
Toffol, E., Hätönen, T., Tanskanen, A. J., Lönnqvist, J. K., Wahlbeck, K., Joffe, G., Tiihonen, J., Haukka, J. K., & Partonen, T. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.055 · Cited by 76
Self-citationAssociation Between Zolpidem and Suicide: A Nationwide Population-Based Case-Control Study
Sun, Y., Lin, C.-C., Lu, C.-J., Hsu, C. Y., & Kao, C. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.10.022 · Cited by 74
Taipale, H., Tanskanen, A., Koponen, M., Tolppanen, A.-M., Tiihonen, J., & Hartikainen, S. (2016) · Clinical Epidemiology · doi:10.2147/clep.s116160 · Cited by 72
Self-citationForsman, J., Taipale, H. T., Masterman, T., Tiihonen, J., & Tanskanen, A. J. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02707-z · Cited by 52
Self-citationDrug exposure in register-based research—An expert-opinion based evaluation of methods
Tanskanen, A., Taipale, H., Koponen, M., Tolppanen, A.-M., Hartikainen, S., Ahonen, R., & Tiihonen, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184070 · Cited by 49
Self-citationMedication and suicide risk in schizophrenia: A nested case–control study
Reutfors, J., Bahmanyar, S., Jönsson, E. G., Brandt, L., Bodén, R., Ekbom, A., & Ösby, U. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.09.001 · Cited by 45
Clozapine Reduces Violent Behavior in Heterogeneous Diagnostic Groups
Kraus, J. E., & Sheitman, B. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.1.36 · Cited by 44
Forsman, J., Taipale, H. T., Masterman, T., Tiihonen, J., & Tanskanen, A. J. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4426 · Cited by 34
Self-citationEpidemiologic study of aripiprazole use and the incidence of suicide events
Ulcickas Yood, M., DeLorenze, G., Quesenberry, C. P., Tsai, A., Phillips, S., Willey, V. J., Niemcryk, S. J., Wells, K., Skovron, M. L., Cziraky, M. J., et al. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2047 · Cited by 22
Acute akathisia with suicidal ideation associated with low dose aripiprazole.
Padder, T. A., Skodnek, K. B., Hashmi, S., Samad, M., Udyawar, A., Azhar, N., & Jaghab, K. (2006) · PubMed Central · Cited by 8
Research works printed but not linked: 1
- 29. Kraus JE, Sheitman BB. Clozapine reduces violent behavior in groups. J Neuropsychiatr. 2005;17(1):36-44. · doi:10.1176/jnp.17.1.36
Cited by
Suicide in young people: screening, risk assessment, and intervention
Hughes, J. L., Horowitz, L. M., Ackerman, J. P., Adrian, M. C., Campo, J. V., & Bridge, J. A. (2023) · BMJ · doi:10.1136/bmj-2022-070630 · Cited by 135
The Lancet Commission on self-harm
Moran, P., Chandler, A., Dudgeon, P., Kirtley, O. J., Knipe, D. W., Pirkis, J., Sinyor, M., Allister, R., Ansloos, J. P., Ball, M. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01121-8 · Cited by 160
Prevention of suicide by clozapine in mental disorders: systematic review
Masdrakis, V. G., & Baldwin, D. S. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.12.011 · Cited by 103
“Additionally, it dramatically and chronically increases peripheral norepinephrine levels ( Green et al., 1993 ; Taipale et al., 2021 ).”
Influentialde Bartolomeis, A., Vellucci, L., Barone, A., Manchia, M., Luca, V. D., Iasevoli, F., & Correll, C. U. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108236 · Cited by 98
Huang, C.-Y., Fang, S., & Shao, Y. J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8810 · Cited by 70
Metadata
- Authors
- Taipale, H., Lähteenvuo, M., Tanskanen, A., Mittendorfer-Rutz, E., & Tiihonen, J.
- Affiliations
- University of Eastern Finland (FI)
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Corresponding author
- Taipale, Heidi
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-08-15
- Volume
- 47
- Issue
- 1
- Pages
- 23-30
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC7824993
- OpenAlex
- W3028392069
- Cited by
- 85
- References
- 37
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 16 · 2023: 11 · 2022: 14 · 2021: 11 · 2020: 2
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Schizophrenia Bulletin (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Finnish Ministry of Social Affairs and Health
- Academy of Finland (315969, 320107)
- Finnish Medical Foundation
- Emil Aaltonen Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- schizophrenia, antipsychotic drugs
- MeSH terms
- Suicide, Completed, Adolescent, Adult, Clozapine, Female, Finland, Humans, Male, Middle Aged, Registries, Risk, Schizophrenia, Suicide, Attempted, Sweden, Antipsychotic Agents, Cohort Studies, Young Adult, Comparative Effectiveness Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.